Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
T Cells
100%
Activated T Lymphocytes
100%
Recombinant interleukin-2
100%
Interferon-α (IFN-α)
50%
Fever
25%
Cytotoxicity
25%
Flow Cytometry
25%
Tumor Necrosis Factor-α
25%
Interleukin-2
25%
Natural Killer
25%
Antitumor Activity
25%
Lymphocytosis
25%
Enzyme-linked Immunosorbent Assay (ELISA)
25%
Proliferating Cells
25%
Tumor Targeting
25%
Serum Levels
25%
Thrombocytopenia
25%
IgG Antibody
25%
Treatment Cycle
25%
Partial Response
25%
Diarrhea
25%
Growth in Vitro
25%
Kaposi Sarcoma
25%
Myelodysplastic Syndrome
25%
Ongoing Trials
25%
Peripheral Blood
25%
Cell Growth
25%
Dose-limiting Toxicity
25%
Maximum Tolerated Dose
25%
IV Infusion
25%
Mitogenic Response
25%
OKT3
25%
Transferrin Receptor 1 (TfR1)
25%
Advanced Malignancies
25%
Lymphokines
25%
Soluble interleukin-2 Receptor (sIL-2R)
25%
Phytohemagglutinin
25%
T Cell Subsets
25%
Consequences of Treatment
25%
Tolerated Dose
25%
Cell Pools
25%
In Vitro Cytotoxicity
25%
Cetus
25%
Well Tolerated
25%
During Treatment
25%
Escalating Dose
25%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Recombinant Interleukin 2
100%
Cytotoxicity
100%
Flow Cytometry
50%
Neoplasm
50%
Tumor Necrosis Factor
50%
Receptor
50%
Thrombocytopenia
50%
Enzyme-Linked Immunosorbent Assay
50%
Antitumor Activity
50%
Myelodysplastic Syndrome
50%
Maximum Tolerated Dose
50%
Diarrhea
50%
Phytohaemagglutinin
50%
Lymphokine
50%
Kaposi Sarcoma
50%
Immunoglobulin G
50%
Transferrin Receptor
50%
Lymphocytosis
50%
Immunology and Microbiology
T Cell
100%
Recombinant Interleukin 2
100%
interferon
40%
Cytotoxicity
40%
In Vitro
40%
Cell Proliferation
20%
Antineoplastic Activity
20%
Tumor Necrosis Factor
20%
Enzyme-Linked Immunosorbent Assay
20%
Blood Level
20%
T Cell Subset
20%
Cell Growth
20%
Immunoglobulin G
20%
Phytohaemagglutinin
20%
Lymphokine
20%
IL-2 Receptor
20%
Mitogenesis
20%
Maximum Tolerated Dose
20%